We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$102B
AUM Growth
-$16.3B
Cap. Flow
+$749M
Cap. Flow %
0.73%
Top 10 Hldgs %
23.72%
Holding
4,322
New
210
Increased
1,790
Reduced
1,850
Closed
304
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HMC icon
1326
Honda
HMC
$41.1B
$5.64M 0.01%
233,712
+62,853
+37% +$1.61M
DCI icon
1327
Donaldson
DCI
$11.2B
$5.64M 0.01%
117,175
-1,191
-1% -$60K
ALTR
1328
DELISTED
Altair Engineering Inc
ALTR
$5.62M 0.01%
106,989
+3,914
+4% +$214K
FLEX icon
1329
Flex
FLEX
$45.2B
$5.61M 0.01%
514,575
+53,311
+12% +$660K
BKI
1330
DELISTED
Black Knight, Inc. Common Stock
BKI
$5.61M 0.01%
85,803
-12,923
-13% -$870K
IQDG icon
1331
WisdomTree International Quality Dividend Growth Fund
IQDG
$731M
$5.6M 0.01%
189,195
-155,740
-45% -$5.15M
ACM icon
1332
Aecom
ACM
$8.62B
$5.6M 0.01%
85,881
-7,778
-8% -$544K
FUMB icon
1333
First Trust Ultra Short Duration Municipal ETF
FUMB
$248M
$5.6M 0.01%
280,315
-105,903
-27% -$2.11M
PDI icon
1334
PIMCO Dynamic Income Fund
PDI
$7.45B
$5.57M 0.01%
267,023
-25,759
-9% -$571K
SGEN
1335
DELISTED
Seagen Inc. Common Stock
SGEN
$5.57M 0.01%
31,462
+3,303
+12% +$476K
RIVN icon
1336
Rivian
RIVN
$23.7B
$5.52M 0.01%
214,312
+35,297
+20% +$1.1M
VOYA icon
1337
Voya Financial
VOYA
$8.9B
$5.52M 0.01%
92,654
+112
+0.1% +$7.2K
TIPZ icon
1338
PIMCO Broad US TIPS Index Exchange-Traded Fund
TIPZ
$88.2M
$5.51M 0.01%
95,721
-966
-1% -$58.1K
HWC icon
1339
Hancock Whitney
HWC
$6.28B
$5.5M 0.01%
124,006
-1,005
-0.8% -$47.8K
SNDR icon
1340
Schneider National
SNDR
$6.12B
$5.5M 0.01%
245,536
+19,525
+9% +$450K
MFC icon
1341
Manulife Financial
MFC
$72.7B
$5.49M 0.01%
316,540
-22,929
-7% -$433K
BMRN icon
1342
BioMarin Pharmaceuticals
BMRN
$13.5B
$5.48M 0.01%
66,134
+19,378
+41% +$1.54M
UPGD icon
1343
Invesco Bloomberg Analyst Rating Improvers ETF
UPGD
$121M
$5.47M 0.01%
107,041
+7,344
+7% +$410K
SEM
1344
DELISTED
Select Medical
SEM
$5.47M 0.01%
430,130
+20,128
+5% +$258K
LYFT icon
1345
Lyft
LYFT
$6.64B
$5.47M 0.01%
411,810
+29,612
+8% +$690K
RFV icon
1346
Invesco S&P MidCap 400 Pure Value ETF
RFV
$340M
$5.46M 0.01%
65,672
+54,417
+483% +$4.92M
FRT icon
1347
Federal Realty Investment Trust
FRT
$10.1B
$5.45M 0.01%
56,875
+3,408
+6% +$383K
DNP icon
1348
DNP Select Income Fund
DNP
$4.1B
$5.44M 0.01%
501,706
+79,775
+19% +$899K
DBE icon
1349
Invesco DB Energy Fund
DBE
$91.6M
$5.43M 0.01%
207,421
-6,944
-3% -$184K
ARKG icon
1350
ARK Genomic Revolution ETF
ARKG
$1.79B
$5.41M 0.01%
171,637
-2,887
-2% -$101K

Similar funds

Raymond James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Raymond James & Associates held 4,322 positions worth $102B, down 14% from $119B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2022 filing shows 210 new, 1,790 increased, 1,850 reduced and 304 closed positions. Its largest new stake was Aspen Technology Inc: 54,037 shares worth $9.93M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2022 buy was Aspen Technology Inc: 54,037 shares worth $9.93M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $471M increase.
  • Raymond James & Associates's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $21.5M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $102B portfolio in Q2 2022.
  • Raymond James & Associates opened 210 new positions and closed 304 in Q2 2022.
  • Raymond James & Associates's portfolio value fell 14% quarter-over-quarter to $102B.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.